Evidence map›Paper›PMID 36445406›Full record

Observational studyBrain : a journal of neurology2023

Metabolic patterns in brain 18F-fluorodeoxyglucose PET relate to aetiology in paediatric dystonia.

Stavros Tsagkaris, Eric K C Yau, Verity McClelland, Apostolos Papandreou, Ata Siddiqui, Daniel E Lumsden, Margaret Kaminska, Eric Guedj, Alexander Hammers, Jean-Pierre Lin

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Brain : a journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Stavros TsagkarisChildren's Neurosciences, Complex Motor Disorders Service (CMDS), Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 7EH, UK.ORCID 0000-0002-9637-567X
Eric K C YauDepartment of Paediatrics & Adolescent Medicine, Princess Margaret Hospital, Kowloon, Hong Kong.
Verity McClellandChildren's Neurosciences, Complex Motor Disorders Service (CMDS), Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 7EH, UK.
Apostolos PapandreouChildren's Neurosciences, Complex Motor Disorders Service (CMDS), Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 7EH, UK.ORCID 0000-0002-3537-9714
Ata SiddiquiNeuroradiology Department, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 7EH, UK.
Daniel E LumsdenChildren's Neurosciences, Complex Motor Disorders Service (CMDS), Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 7EH, UK.
Margaret KaminskaChildren's Neurosciences, Complex Motor Disorders Service (CMDS), Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 7EH, UK.
Eric GuedjCERIMED, Nuclear Medicine Department, Aix Marseille Universite, APHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, 13397 Marseille, France.
Alexander HammersKing's College London & Guy's and St Thomas' PET Centre, Division of Biomedical Engineering and Imaging Sciences, King's College London, London SE1 7EH, UK.
Jean-Pierre LinChildren's Neurosciences, Complex Motor Disorders Service (CMDS), Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust (GSTT), London SE1 7EH, UK.ORCID 0000-0001-9314-2259
King's College London · GBGuy's and St Thomas' NHS Foundation Trust · GBCentre National de la Recherche Scientifique · FR

Funding

Medical Research Council MR/N013042/1Medical Research Council MR/P006868/1Medical Research Council MR/T005424/1Medical Research Council MR/W015692/1Wellcome Trust
6 · The paper itself

Abstract

There is a lack of imaging markers revealing the functional characteristics of different brain regions in paediatric dystonia. In this observational study, we assessed the utility of [18F]2-fluoro-2-deoxy-D-glucose (FDG)-PET in understanding dystonia pathophysiology by revealing specific resting awake brain glucose metabolism patterns in different childhood dystonia subgroups. PET scans from 267 children with dystonia being evaluated for possible deep brain stimulation surgery between September 2007 and February 2018 at Evelina London Children's Hospital (ELCH), UK, were examined. Scans without gross anatomical abnormality (e.g. large cysts, significant ventriculomegaly; n = 240) were analysed with Statistical Parametric Mapping (SPM12). Glucose metabolism patterns were examined in the 144/240 (60%) cases with the 10 commonest childhood-onset dystonias, focusing on nine anatomical regions. A group of 39 adult controls was used for comparisons. The genetic dystonias were associated with the following genes: TOR1A, THAP1, SGCE, KMT2B, HPRT1 (Lesch Nyhan disease), PANK2 and GCDH (Glutaric Aciduria type 1). The acquired cerebral palsy (CP) cases were divided into those related to prematurity (CP-Preterm), neonatal jaundice/kernicterus (CP-Kernicterus) and hypoxic-ischaemic encephalopathy (CP-Term). Each dystonia subgroup had distinct patterns of altered FDG-PET uptake. Focal glucose hypometabolism of the pallidi, putamina or both, was the commonest finding, except in PANK2, where basal ganglia metabolism appeared normal. HPRT1 uniquely showed glucose hypometabolism across all nine cerebral regions. Temporal lobe glucose hypometabolism was found in KMT2B, HPRT1 and CP-Kernicterus. Frontal lobe hypometabolism was found in SGCE, HPRT1 and PANK2. Thalamic and brainstem hypometabolism were seen only in HPRT1, CP-Preterm and CP-term dystonia cases. The combination of frontal and parietal lobe hypermetabolism was uniquely found in CP-term cases. PANK2 cases showed a distinct combination of parietal hypermetabolism with cerebellar hypometabolism but intact putaminal-pallidal glucose metabolism. HPRT1, PANK2, CP-kernicterus and CP-preterm cases had cerebellar and insula glucose hypometabolism as well as parietal glucose hypermetabolism. The study findings offer insights into the pathophysiology of dystonia and support the network theory for dystonia pathogenesis. 'Signature' patterns for each dystonia subgroup could be a useful biomarker to guide differential diagnosis and inform personalized management strategies.

Indexed as

Cerebral PalsyDystoniaDystonic DisordersKernicterusAdultAmino Acid Metabolism, Inborn ErrorsApoptosis Regulatory ProteinsBrainBrain Diseases, MetabolicChildDNA-Binding ProteinsFluorodeoxyglucose F18GlucoseGlutaryl-CoA DehydrogenaseHumansInfant, NewbornApoptosis Regulatory ProteinsDNA-Binding ProteinsFluorodeoxyglucose F18GlucoseGlutaryl-CoA DehydrogenaseMolecular ChaperonesTHAP1 protein, humanTOR1A protein, humandystonic cerebral palsyinherited childhood dystoniaPET functional imaging

Identifiers

PMID36445406
PMCPMC10232264
OpenAlexW4310360172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.